CELC celcuity.com: Total Company Value-to-Revenue Ratio

celcuity.com (CELC) - corporate logo

A high concentration on cellular platforms creates risks, which are clearly demonstrated by the company's price-to-sales ratio. However, the 0.00 mark characterizes this parameter within the context of the Celcuity Inc. (CELC) CEL-signia precision oncology strategy for therapy selection. The advantage of live-cell analysis allows for premium pricing, which, combined with the development of proprietary drugs, ensures the fundamental stability of the business.

Celcuity (CELC) EV/Sales Multiple: for the period 11/23/2025 - 11/20/2026

Celcuity Therapeutics - analytical breakdowns and key metrics (CELC)

- market price and analyst price targets:
Fundamental valuation:CELC - Celcuity Inc.
Flagship merchandise of Celcuity Corp

To objectively analyze asset quality, one should evaluate the business's enterprise value excluding debt, which helps identify unjustified price growth. The EV-to-revenue trend demonstrates the real price of one dollar of revenue, helping investors timely recognize speculative valuation overheating for Celcuity Inc. (CELC) amid the scaling of its diagnostic alliances with pharma behemoths.